$50.07
0.611.23%
Last update: Oct 20, 12:48 PM
$49.99
0.531.07%
GSK PLC
GSKNYSE
GSK (GSK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
GSK (GSK) last issued guidance on July 28, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.9 - $5, compared to a consensus EPS estimate of $4.79. GSK also guided revenue in the range of $44.75B - $44.75B for the period.
Compared to prior guidance, GSK maintained its EPS outlook from a previous range of $4.9 - $5. On the revenue side, the company maintained its revenue forecast from a prior range of $44.75B - $44.75B.
GSK has issued 16 guidance updates between November 2, 2022 and July 28, 2026. During this period, the company raised its outlook 6 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.27 | $1.17 | $0.64 | $1.26 |
| Actual | $1.35 | $1.25 | $0.68 | $1.48 |
| Surprise | +6.61% | +6.84% | +6.25% | +17.8% |
| Revenue | ||||
| Estimate | $10.79B | $10.19B | $11.19B | $11.16B |
| Actual | $11.28B | $10.30B | $11.46B | $11.53B |
| Surprise | +4.54% | +1.07% | +2.41% | +3.29% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.40 | $0.78 | $1.27 | $1.35 |
| Revenue | ||||
| Consensus | $11.80B | $12.09B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 28, 2026 | $1.35 | $1.27 | 6.61 % |
| Q1 | Apr 29, 2026 | $1.25 | $1.17 | 6.84 % |
| Q4 | Feb 4, 2026 | $0.68 | $0.64 | 6.25 % |
| Q3 | Oct 29, 2025 | $1.48 | $1.26 | 17.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 28, 2026 | $11.28B | $10.79B | 4.54 % |
| Q1 | Apr 29, 2026 | $10.30B | $10.19B | 1.07 % |
| Q4 | Feb 4, 2026 | $11.46B | $11.19B | 2.41 % |
| Q3 | Oct 29, 2025 | $11.53B | $11.16B | 3.29 % |
